-
LEO Pharma Receives Positive CHMP Opinion of Adtralza (tralokinumab) for the Treatment of Adults Wit
NOT FOR DISTRIBUTION IN THE UK OR IRELAND If authorized, Adtralza (tralokinumab) will be the first approved biologic that specifically targets the IL-13 cytokine, a key driver of atopic dermatitis sig…- 18
- 0
-
$优惠劵使用时效：无法使用使用时效：
之前
使用时效：永久有效优惠劵ID：×